Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Obstetrics and Gynecology

How Does Surgery Cause Scar Tissue in Asherman Syndrome?

At a Glance

In Asherman syndrome, deep injury during a uterine procedure can damage the foundational layer that rebuilds the uterine lining. The wound may then heal with collagen-rich scar bands instead of normal tissue; infection can increase risk but is not required.

When your uterus heals by forming scar tissue (adhesions) instead of a healthy lining, it is usually because the deep, foundational layer of your endometrium has been injured. Normally, the uterus sheds and regenerates its lining every month. However, when deep surgical trauma—such as during a D&C (dilation and curettage)—damages this root layer, the body’s normal regeneration process can be disrupted [1]. Instead of fully rebuilding the soft, blood-rich tissue, the immune system triggers a repair response that can patch the damage with fibrotic scar tissue [1]. This can lead to the adhesions characteristic of Asherman syndrome, where opposing walls of the uterus may stick together [2]. Not every injury causes Asherman syndrome, and the extent of adhesions and functional loss varies widely from person to person [3].

The Role of the Basal Layer

The lining of your uterus (the endometrium) has two main layers: the functional layer that grows and sheds during your period, and the basal layer underneath it. The basal layer acts as the foundational root system. It contains the essential stem cells [4] and blood vessels [5] required to regrow the functional layer every month.

When a surgical procedure goes deep enough to damage this basal layer, it can impair the uterus’s ability to rebuild the soft, spongy lining it needs for menstruation and pregnancy [1][6]. If the normal lining cannot fully regenerate, the raw surfaces inside the uterine cavity may heal together, forming bands of scar tissue [1]. This structural change helps explain common symptoms of Asherman syndrome, such as significantly lighter or absent periods and difficulties supporting a pregnancy [1].

The Inflammatory Repair Response

When the basal layer is damaged, the immune system rushes in to protect the area, creating an inflammatory response [7]. In a healthy, superficial cut, inflammation settles down once the wound is closed. But in deep uterine trauma, research suggests this inflammation can sometimes become persistent [7].

During this process, specialized repair cells called macrophages release signals that prioritize rapid wound closure over careful tissue regeneration [8][9]. As a result, the body produces collagen-heavy scar tissue to seal the injury [2].

Cellular Changes: A Current Research Model

Researchers are still studying exactly how normal uterine cells turn into scar tissue. One leading theory involves complex biological mechanisms called epithelial-mesenchymal transition (EMT) and endothelial-to-mesenchymal transition (EndMT) [10].

In laboratory and animal studies, intense inflammatory signals can cause the normal cells lining the uterus and blood vessels to change their behavior [11][10]. Through EMT and EndMT, these cells are thought to transition into myofibroblasts—heavy-duty repair cells [10][12]. Instead of building delicate glands, myofibroblasts produce structural proteins like collagen, creating thick, stiff scar tissue designed to seal the wound [2][13]. While this is a proposed explanation based on ongoing research rather than settled human biology, it helps scientists understand why the uterus sometimes struggles to regenerate healthy tissue [14].

The Role of Infection

Surgical trauma alone can be sufficient to cause Asherman syndrome, but a concurrent infection can increase the risk of developing severe scar tissue [15]. An infection can amplify the inflammatory response, causing it to last longer and potentially recruit more scar-producing cells [15][16]. However, an infection is not required for adhesions to form, and many patients develop Asherman syndrome without any history of infection [16].

(Note: If you recently had a uterine procedure and are experiencing a fever, worsening pelvic pain, foul-smelling discharge, or heavy bleeding, contact your healthcare provider promptly, as these can be signs of an active infection.)

Common questions in this guide

How does uterine surgery cause scar tissue in Asherman syndrome?
Deep surgery can injure the basal layer, the foundational part of the uterine lining that contains cells and blood vessels needed for monthly regrowth. If the lining cannot fully regenerate, exposed surfaces in the uterine cavity may heal together as bands of scar tissue called adhesions. These adhesions are the defining structural change in Asherman syndrome.
Why is the basal layer of the uterine lining important?
The basal layer supports monthly rebuilding of the uterine lining because it contains essential stem cells and blood vessels. When a procedure damages this deeper layer, the uterus may not restore a healthy lining, which can contribute to lighter or absent periods and pregnancy difficulties.
Does an infection have to be present for Asherman syndrome to develop?
No. Deep surgical trauma can cause Asherman syndrome without an infection, although an infection may intensify inflammation and increase the risk of more severe adhesions. The absence of remembered infection does not rule out Asherman syndrome.
What symptoms can uterine adhesions cause?
Uterine adhesions may cause periods to become much lighter or stop altogether. They can also make it harder to support a pregnancy or achieve fertility goals. Symptoms and the amount of functional loss vary from person to person.
How are uterine adhesions evaluated and treated?
A clinician may use hysteroscopy or imaging to assess where the adhesions are located and how extensive or dense they are. Adhesiolysis is a procedure used to cut and remove scar tissue, and some patients may be offered a balloon stent or hormone therapy afterward to help keep the uterine walls separated while they heal. Follow-up cavity assessment helps evaluate recovery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my hysteroscopy or imaging, what is the location, density, and extent of the adhesions in my uterine cavity?
  2. 2.How much normal-appearing, healthy endometrial lining remains visible?
  3. 3.What surgical techniques do you use during adhesiolysis (the surgical cutting and removal of scar tissue) to protect the remaining healthy lining?
  4. 4.Do you recommend any post-operative prevention strategies, such as balloon stents (a small inflatable device placed in the uterus) or hormone therapy, to help keep the uterine walls separated while they heal?
  5. 5.What are the risks and evidence behind your recommended prevention strategy, and when should we schedule a follow-up cavity assessment?
  6. 6.Given the severity of my adhesions, what is the realistic plan for my menstrual recovery or fertility goals?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

    Ma H, Yang M

    Obstetrical & gynecological survey 2026; (81(6)):293-303 doi:10.1097/OGX.0000000000001555.

    PMID: 42241335
  2. 2

    Elevated NF-κB signaling in Asherman syndrome patients and animal models.

    Wang X, Ma N, Sun Q, et al.

    Oncotarget 2017; (8(9)):15399-15406 doi:10.18632/oncotarget.14853.

    PMID: 28148903
  3. 3

    Results of centralized Asherman surgery, 2003-2013.

    Hanstede MM, van der Meij E, Goedemans L, Emanuel MH

    Fertility and sterility 2015; (104(6)):1561-8.e1.

    PMID: 26428306
  4. 4

    Endothelial senescence induced by PAI-1 promotes endometrial fibrosis.

    Wu J, Wang J, Pei Z, et al.

    Cell death discovery 2025; (11(1)):89 doi:10.1038/s41420-025-02377-0.

    PMID: 40050610
  5. 5

    The expression of marker for endometrial stem cell and fibrosis was increased in intrauterine adhesious.

    Hu J, Zeng B, Jiang X, et al.

    International journal of clinical and experimental pathology 2015; (8(2)):1525-34.

    PMID: 25973037
  6. 6

    Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.

    Lee WL, Liu CH, Cheng M, et al.

    International journal of molecular sciences 2021; (22(10)) doi:10.3390/ijms22105175.

    PMID: 34068335
  7. 7

    The activation of cGAS-STING pathway promotes the epithelial-mesenchymal transition and inflammation in intrauterine adhesion.

    Wu X, He L, Lin Y, et al.

    International immunopharmacology 2025; (159()):114840 doi:10.1016/j.intimp.2025.114840.

    PMID: 40409098
  8. 8

    Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome.

    Lv H, Sun H, Wang L, et al.

    EMBO molecular medicine 2023; (15(9)):e17601 doi:10.15252/emmm.202317601.

    PMID: 37519221
  9. 9

    Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH.

    Yao S, Zhou Z, Wang L, et al.

    iScience 2023; (26(7)):107201 doi:10.1016/j.isci.2023.107201.

    PMID: 37456855
  10. 10

    EndMT: New findings on the origin of myofibroblasts in endometrial fibrosis of intrauterine adhesions.

    Xu C, Bao M, Fan X, et al.

    Reproductive biology and endocrinology : RB&E 2022; (20(1)):9 doi:10.1186/s12958-022-00887-5.

    PMID: 34996477
  11. 11

    Endoplasmic reticulum stress promotes endometrial fibrosis through the TGF-β/SMAD pathway.

    Bao M, Feng Q, Zou L, et al.

    Reproduction (Cambridge, England) 2023; (165(2)):171-182 doi:10.1530/REP-22-0294.

    PMID: 36342661
  12. 12

    Smad signaling coincides with epithelial-mesenchymal transition in a rat model of intrauterine adhesion.

    Guo LP, Chen LM, Chen F, et al.

    American journal of translational research 2019; (11(8)):4726-4737.

    PMID: 31497194
  13. 13

    High Molecular Weight Hyaluronic Acid Inhibits Fibrosis of Endometrium.

    Zhu Y, Hu J, Yu T, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2016; (22()):3438-3445 doi:10.12659/msm.896028.

    PMID: 27670361
  14. 14

    Apelin-13 alleviates intrauterine adhesion by inhibiting epithelial-mesenchymal transition of endometrial epithelial cells and promoting angiogenesis.

    Zhao Q, Li Y, Zhao X, et al.

    Human cell 2024; (37(6)):1613-1623 doi:10.1007/s13577-024-01117-3.

    PMID: 39158615
  15. 15

    Evaluation of different rat models intrauterine adhesion models and improvement of the technique for their establishment.

    Xi J, Pan Y, Jin C, et al.

    Experimental animals 2023; (72(2)):274-284 doi:10.1538/expanim.22-0153.

    PMID: 36642541
  16. 16

    Establishment and comparison of different intrauterine adhesion modelling procedures in rats.

    Sun L, Zhang S, Chang Q, Tan J

    Reproduction, fertility, and development 2019; (31(8)):1360-1368 doi:10.1071/RD18397.

    PMID: 30958978

This page explains how uterine surgery and inflammation may contribute to Asherman syndrome for informational purposes only; it does not constitute medical advice. Ask a gynecologist about your symptoms and care.

Get notified when new evidence is published on Asherman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.